Clinical Trials Browser

Phase 2 × Breast Neoplasms × gedatolisib × Clear all

NCT03698383 2021-02-18

Phase II Study of Herzuma® Plus Gedatolisib in Patients With HER-2 Positive Metastatic Breast Cancer

Phase 2 Unknown

Breast Neoplasms